Circulating fatty acid binding protein 4 (FABP-4) concentrations and mortality in individuals with colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study
- PMID: 40857027
- DOI: 10.1002/ijc.70090
Circulating fatty acid binding protein 4 (FABP-4) concentrations and mortality in individuals with colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study
Abstract
Human fatty acid binding protein-4 (FABP-4), a protein elevated in obesity that promotes colon cancer cell invasiveness and metastasis, may be associated with higher mortality in individuals with colorectal cancer (CRC) and may serve as a mediator of the obesity-mortality association in these individuals. We used a causal diagram to inform covariate selection and applied Cox proportional hazards models to estimate hazard ratios (HRs) for CRC-specific, non-CRC-specific, and all-cause mortality by FABP-4 levels measured in baseline blood samples from 1371 incident CRC cases from the European Prospective Investigation into Cancer and Nutrition cohort. Competing risk analyses were adapted for CRC and non-CRC deaths. Mediation analyses were conducted to estimate total effects (TEs), direct effects (DEs), and mediation proportions (MPs) by FABP-4 of pre-diagnostic body mass index (BMI) on mortality. In the fully adjusted model including BMI, higher circulating FABP-4 concentrations were associated with higher CRC mortality (HRQ4vsQ1 = 1.49; 95% CI: 1.11-2.00) and all-cause mortality (HRQ4vsQ1 = 1.49; 95% CI: 1.15-1.93), but not statistically associated with non-CRC mortality (HRQ4vsQ1 = 1.51; 95% CI: 0.82-2.76). The TE and DE per 5 kg/m2 of BMI on all-cause mortality were 1.21; 95% CI: 1.10-1.34, and 1.13; 95% CI: 1.02-1.26, respectively, with a MP of 34.5% (p = .002) by FABP-4. For CRC-specific and non-CRC-specific mortality, MPs by FABP-4 were 33.7% (p = .03) and 36.1% (p = .02), respectively. In conclusion, higher concentrations of FABP-4 were associated with higher CRC-specific and all-cause mortality in individuals with CRC. FABP-4 was a significant partial mediator of the adiposity-mortality relationship in individuals with CRC.
Keywords: EPIC; FABP‐4; human fatty acid binding protein‐4; incident colorectal cancer; mortality.
© 2025 The Author(s). International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
References
REFERENCES
-
- Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:1‐253.
-
- Clinton SK, Giovannucci EL, Hursting SD. The World Cancer Research Fund/American Institute for Cancer Research third expert report on diet, nutrition, physical activity, and cancer: impact and future directions. J Nutr. 2020;150:663‐671.
-
- Lee J, Meyerhardt JA, Giovannucci E, Jeon JY. Association between body mass index and prognosis of colorectal cancer: a meta‐analysis of prospective cohort studies. PLoS One. 2015;10:e0120706.
-
- van Zutphen M, Kampman E, Giovannucci EL, van Duijnhoven FJB. Lifestyle after colorectal cancer diagnosis in relation to survival and recurrence: a review of the literature. Curr Colorect Cancer Rep. 2017;13:370‐401.
-
- Fedirko V, Romieu I, Aleksandrova K, et al. Pre‐diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations. Int J Cancer. 2014;135:1949‐1960.
Grants and funding
- International Agency for Research on Cancer (IARC)
- Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London
- Danish Cancer Society
- Ligue Contre le Cancer
- Institut Gustave Roussy
- Mutuelle Générale de l'Education Nationale
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- German Cancer Aid
- German Cancer Research Center (DKFZ)
- German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE)
- Federal Ministry of Education and Research (BMBF)
- Associazione Italiana per la Ricerca sul Cancro-AIRC-Italy
- Compagnia di SanPaolo and National Research Council
- Dutch Ministry of Public Health, Welfare and Sports (VWS)
- Netherlands Cancer Registry (NKR)
- LK Research Funds
- Dutch Prevention Funds
- Dutch ZON (Zorg Onderzoek Nederland)
- World Cancer Research Fund (WCRF)
- Statistics Netherlands (The Netherlands)
- Health Research Fund (FIS)-Instituto de Salud Carlos III (ISCIII)
- Regional Governments of Andalucía, Asturias, Basque Country, Murcia and Navarra, and the Catalan Institute of Oncology-ICO
- Swedish Cancer Society
- Swedish Research Council and County Councils of Skåne and Västerbotten
- 14136 to EPIC-Norfolk; C8221/A29017 to EPIC-Oxford/CRUK_/Cancer Research UK/United Kingdom
- 1000143 to EPIC-Norfolk; MR/M012190/1 to EPIC-Oxford/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Research Materials
